TREVIAMET TABS 50/850MG 14`S

Treviamet Tablets 50/850mg (14’s) are a powerful combination therapy for managing type 2 diabetes. Each tablet contains:

1. Sitagliptin (50mg): A DPP-4 inhibitor that increases insulin release and reduces glucose production by enhancing incretin hormone activity.
2. Metformin (850mg): A trusted biguanide that decreases glucose production in the liver and improves the body’s sensitivity to insulin.

This dual-action medication is designed to provide better glycemic control, complementing diet and exercise efforts. Treviamet is particularly suitable for patients who require both metformin and sitagliptin to achieve their blood sugar targets.

Key Benefits:

• Dual Mechanism: Combines two complementary diabetes medications for enhanced blood sugar control.
• Improves Insulin Function: Supports the body’s natural insulin response and reduces insulin resistance.
• Convenient Dosing: Combines two medications in a single tablet for simplified treatment.

Dosage and Administration:

• Recommended Dose: One tablet twice daily, with meals to reduce gastrointestinal side effects.
• Administration: Always take as prescribed by a healthcare provider.

Precautions:

• Kidney and Liver Function: Not recommended for patients with severe kidney or liver impairment.
• Lactic Acidosis Risk: Metformin may rarely cause lactic acidosis; monitor for symptoms like muscle pain or unusual fatigue.
• Pregnancy and Breastfeeding: Consult your doctor before use.

Possible Side Effects:

• Common: Nausea, diarrhea, stomach upset, or mild hypoglycemia.
• Rare: Allergic reactions, lactic acidosis, or pancreatitis; seek immediate medical attention if these occur.